68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
Saved in:
| Main Authors: | Yu Zhang, Qingqing Li, Fengling Shan, Ao Li, Danni Li, Xiaoxu Dong, Zhiyi Lin, Xiao Li, Shuai Xue, Wenxin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c03248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
by: Yvonne A. Evrard, et al.
Published: (2025-05-01) -
Optimizing Standardization Systems and Standardizing Clinical Practice: Interpretation of Quality Standards for Medical 68Ge/68Ga Generators and 68Ga Radiopharmaceuticals and Quality Standards for Medical 177Lu and Its Radiopharmaceuticals
by: LAI Yuxin, et al.
Published: (2025-07-01) -
EVALUATION OF 68Ge/68Ga GENERATOR PRE-ELUTION EFFICIENCY ON METALLIC IMPURITIES IN THE COMPOSITION OF 68GaPSMA-11 RADIOPHARMACEUTICAL IN NUCLEAR MEDICINE PET CHEMISTRY
by: Ayşe Uğur, et al.
Published: (2021-09-01) -
Age- and Gender-Specific Components of the Metabolic Syndrome in 2228 First Graders: The PEP Family Heart Study
by: Peter Schwandt, et al.
Published: (2013-01-01) -
Quantitative whole-body dynamic planar scintigraphy in mice with 99mTc and 161Tb
by: John D. Wright, et al.
Published: (2025-07-01)